ACH
TNGX icon

ArrowMark Colorado Holdings’s Tango Therapeutics TNGX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8M Hold
708,385
– – 0.39% 75
2025
Q4 		$6.28M Hold
708,385
– – 0.14% 176
2025
Q3 		$5.95M Hold
708,385
– – 0.11% 187
2025
Q2 		$3.63M Hold
708,385
– – 0.07% 205
2025
Q1 		$970K Hold
708,385
– – 0.02% 251
2024
Q4 		$2.19M Hold
708,385
– – 0.03% 228
2024
Q3 		$5.45M Hold
708,385
– – 0.07% 183
2024
Q2 		$6.08M Hold
708,385
– – 0.07% 185
2024
Q1 		$5.62M Hold
708,385
– – 0.06% 200
2023
Q4 		$7.01M Buy
+708,385
New +$6.15M 0.08% 177

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

ArrowMark Colorado Holdings's TNGX Position: Q1 2026 in Review

ArrowMark Colorado Holdings held its Tango Therapeutics (TNGX) position steady in Q1 2026 at 708,385 shares worth $14.8M. The position accounts for 0.39% of the portfolio, ranked #75.

ArrowMark Colorado Holdings first reported a position in TNGX in Q4 2023 and has held it in 10 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • ArrowMark Colorado Holdings held 708,385 shares of Tango Therapeutics worth $14.8M as of Q1 2026.
  • ArrowMark Colorado Holdings left its Tango Therapeutics share count unchanged in Q1 2026.
  • Tango Therapeutics made up 0.39% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #75 holding.
  • ArrowMark Colorado Holdings first reported a position in Tango Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.